Ilika Share Discussion Threads

[jotoha2] 11/5/2022 15:14

Clearly these guys are very good at lining their pockets and not to hot at actually doing their business , and all that cash raised will be gone soon enough , no wonder the boys in the far east are market leaders.

[firestorm911] 11/5/2022 12:15

Was a red flag.


21/03/2022 11:45am
UK Regulatory (RNS & others)

Ilika (LSE:IKA)
Historical Stock Chart

From Mar 2022 to May 2022

Click Here for more Ilika Charts.
TIDMIKA

RNS Number : 4521F

Ilika plc

21 March 2022

Ilika plc

("Ilika" or the "Company")

Director/PDMR Shareholding

Ilika (AIM: IKA), a pioneer in solid-state battery technology, announces that between 18 March and 21 March 2022, Steve Boydell, CFO, sold an aggregate of 371,222 shares at an average price of 109p per share. This completes the planned sale of shares resulting from the option exercise announced on 8 March 2022.

[robertspc1] 11/5/2022 12:04

Plenty of panic and rash comments on here. Yes management have let investors down badly, especially those who bought into recent placing etc. But Goliath could still be a game changer with the right partners. They have plenty of cash so can bide their time.

[firestorm911] 11/5/2022 11:58

This will halve, then half again and again.

Hence circa 9.11p

[eddie jackson] 11/5/2022 11:05

This could be a great company with the "right management" in place,shame of this debacle is that there is little hope of any sort of recovery in the near to mid term and in the current economic conditions.A clear out of the board must surely be a priority now and a new high calibre board installed with a clear focus.

I fear this could get a whole lot worse in terms of share price unless something major changes i just hope we dont get down to single digits :-(

[shrout] 11/5/2022 10:47

The warm-up act for Ilika's next AGM..

[phil2003] 11/5/2022 10:28

I’m sticking by my 50p target..
So nobody they’ve spoken to or partnered with over the last few years sees any potential in developing Goliath?!?

“Ilika continues to explore opportunities for closer collaboration with strategic partners interested in aligning their product roadmaps with Goliath.”

[supernumerary] 11/5/2022 10:05

kenjen - opportunities always exceed the capacity available, whether now or in the future. It's an aspect of what I call the addressable market fallacy: 'There's a vast market out there, and we only need to win a tiny percentage to prosper.' But how many ever do?

I presume the 'medical' devices are really smart watches, rings, patches etc with medical sensors? My worry with that sort of app is that they are attached to their users and so can harvest energy continuously, whether from movement or light or pressure change or whatever. Hence their need for storage is not long-term, which is where the batteries score best over capacitors, which have a higher leakage current. So I wonder if there really is a market in such applications, and how big it is?

Good of them to make it clear that Goliath doesn't actually have any strategic partners yet :¬(

Edit: all that said, today's fall does look a bit overdone to me...

[swiss paul] 11/5/2022 09:51

That share graph is some ski slope!

[robertspc1] 11/5/2022 09:06

Management will have some tough questions to answer. Their original intention was to fully outsource Stereax manufacturing but when they couldn't find partners they reversed direction completely to go in house. This was risky as they are now finding out. I suspect that means they will be very keen to go down the partnering licensing route with Goliath.

[horneblower] 11/5/2022 08:49

At least they are consistent.

Consistent at missing their own deadlines.

Consistent at using "Sir Humphrey" speak to big up their failures.

Their RNS contains many classic examples.

Quote...
"Ilika continues to explore opportunities for closer collaboration with strategic partners interested in aligning their product roadmaps with Goliath."

Interpretation...
We will try to find customers whose battery needs match our secret (ie currently underperforming) product standards.

My question is, are they just dissembling to us or do they actually believe it themselves?

[robertspc1] 11/5/2022 08:48

Well Kenjen was right, they have hit a few hurdles on Stereax which is not a surprise but disappointing all the same. Revenues will be deferred probably more than they think as anything medical takes forever. Suspect this might be behind the FDs departure. But Goliath news positive a and strategic discussions underway. Plus plenty of cash. ST pain LT gain

[shammytime] 11/5/2022 08:30

Whoever said 50p yesterday was correct

[kenjen1] 11/5/2022 08:13

Think you are right, mostly priced in and of course the market will react, but they will have learned their lesson about giving unrealistic timelines. You can bet your bottom dollar these timelines have lots of contingency built in! We will be selling to market by autumn

[hatfullofsky] 11/5/2022 07:51

Or sell and buy back cheaper

[hatfullofsky] 11/5/2022 07:50

Tin hats on gentlemen. Switch to medical puts in an additional dependency. Gonna take a hit today but looks like the news was known by a few.

[kenjen1] 11/5/2022 07:38

So we are already in h1 of financial year 23, so building in some contingency I reckon sales will begin October/November. Not ideal but hardly lifechanging :)

Great to see Goliath progress also

[nw99] 11/5/2022 07:36

A bright future

[kenjen1] 11/5/2022 07:35

Glad they addressed the timelines! Finally an update letting us know where we are. Yes disappointing with the slight delay but note the most important aspect! Opportunities outweigh the capacity we have in the future..

[waterloo01] 11/5/2022 07:28

I thought I'd missed the boat when these traded towards and over £2.00. Seems the boat is yet to sail.

[phil2003] 10/5/2022 17:43

Penny share missed its own deadlines and stops selling key product..
Next stop 50p

[kenjen1] 09/5/2022 22:14

Look at Twitter again today. Just reposting a previous tweet from 3 months ago! Why are they not selling the product to the market anymore? Stereax is the key to our immediate success and now we don’t tweet about it? Come on that’s strange to say the least

[kenjen1] 09/5/2022 22:12

Not sure it’s as straight forward as that Robert. The company Rns in November said process qualification would complete before end of 21. With product qualification following shortly after. That’s nothing to do with the tech market that’s missing deadlines they set themselves. Not good enough and the market knows it

[robertspc1] 09/5/2022 19:04

The shares are back where they were 18months ago. The company is in much better shape and much closer to Stereax production and sales and Goliath is progressing steadily. But the tech bubble has well and truly burst so you either take your money and run or take the LT view. Latter for me